Mark W. Frohlich
2014
In 2014, Mark W. Frohlich earned a total compensation of $2M as Executive Vice President, Portfolio Strategy at Juno Therapeutics.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $108,000 |
| Salary | $366,667 |
| Stock Awards | $1,375,000 |
| Total | $2,049,667 |
Frohlich received $1.4M in stock awards, accounting for 67% of the total pay in 2014.
Frohlich also received $200K in bonus, $108K in non-equity incentive plan and $366.7K in salary.
Rankings
In 2014, Mark W. Frohlich's compensation ranked 4,420th out of 13,032 executives tracked by ExecPay. In other words, Frohlich earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,420 out of 13,032 | 66th |
Division Manufacturing | 1,576 out of 4,965 | 68th |
Major group Chemicals And Allied Products | 519 out of 1,690 | 69th |
Industry group Drugs | 399 out of 1,369 | 71st |
Industry Biological Products, Except Diagnostic Substances | 69 out of 241 | 71st |
Source: SEC filing on April 20, 2016.
Frohlich's colleagues
We found two more compensation records of executives who worked with Mark W. Frohlich at Juno Therapeutics in 2014.